Skip to main content
. 2023 Jun 5;18(8):1006–1018. doi: 10.2215/CJN.0000000000000192

Figure 2.

Figure 2

Development of the cohort, definitions of COVID-19–associated AKI, and comparative mortality rates. (A) Overall prevalence of AKI by different AKI definitions in a total of 336,473 adult cohorts. (B) Serum creatinine trajectories by day of admission between patient groups classified in different AKI definitions. (C) 60-day survival after diagnosis of COVID-19 in the patient shown in panel A (this analysis excluded one site with a COVID inpatient mortality rate of <1%).